Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 9
2012 22
2013 32
2014 23
2015 12
2019 4
2020 2
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 25609517

99 results
Results by year
Filters applied: . Clear all
Page 1
Response.
Douketis J, Eikelboom J, Liew A, Bell AD. Douketis J, et al. Can Fam Physician. 2015 Jan;61(1):24-5. Can Fam Physician. 2015. PMID: 25609517 Free PMC article. No abstract available.
Well-managed warfarin is superior to NOACs.
Trusler M. Trusler M. Can Fam Physician. 2015 Jan;61(1):23-4. Can Fam Physician. 2015. PMID: 25609516 Free PMC article. No abstract available.
Response to 'Re: Kakkos et al. Efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials'.
Kakkos SK, Kirkilesis GI, Tsolakis IA. Kakkos SK, et al. Eur J Vasc Endovasc Surg. 2015 Mar;49(3):353-4. doi: 10.1016/j.ejvs.2014.12.007. Epub 2014 Dec 30. Eur J Vasc Endovasc Surg. 2015. PMID: 25556083 Free article. No abstract available.
Re: 'Kakkos et al. Efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials'.
Spanos K, Giannoukas AD. Spanos K, et al. Eur J Vasc Endovasc Surg. 2015 Mar;49(3):353. doi: 10.1016/j.ejvs.2014.11.019. Epub 2014 Dec 30. Eur J Vasc Endovasc Surg. 2015. PMID: 25556084 Free article. No abstract available.
Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'- Key Learning Points for Surgeons.
Hurst KV, Lee R, Milosevic I, Handa A. Hurst KV, et al. Eur J Vasc Endovasc Surg. 2015 Jul;50(1):126-7. doi: 10.1016/j.ejvs.2015.02.022. Epub 2015 Apr 29. Eur J Vasc Endovasc Surg. 2015. PMID: 25933476 Free article. No abstract available.
99 results